Different Metabolic Effects of Statins
NCT01011127 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2010-10-05
Summary
The investigators hypothesize that pravastatin and rosuvastatin may have different metabolic effects in hypercholesterolemic patients.
Conditions
Interventions
- DRUG
-
pravastatin, rosuvastatin
Sponsors & Collaborators
-
Gachon University Gil Medical Center
lead OTHER
Eligibility
- Min Age
- 25 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2010-07-31
- Completion
- 2010-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
Influence of OATP1B1 and BRCP Genotype on Rosuvastatin PK, PD and Lipidomics in Hyperlipidemic Patients
NCT01466608 ·Status: COMPLETED ·Phase: PHASE4
-
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
NCT01352897 ·Status: COMPLETED
-
Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients
NCT03949374 ·Status: COMPLETED ·Phase: PHASE4
-
Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?
NCT00851175 ·Status: COMPLETED ·Phase: PHASE4
-
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
NCT04829149 ·Status: COMPLETED
-
STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges
NCT00654537 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients
NCT02251847 ·Status: UNKNOWN ·Phase: PHASE3
-
Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION
NCT00526721 ·Status: COMPLETED
-
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
NCT00631189 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Rosuvastatin Therapy on HDL2 Level
NCT02593487 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline
NCT03903029 ·Status: COMPLETED
-
Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT03175835 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate PK, PD, and PG of Rosuvastatin in the Elderly
NCT03715101 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk
NCT02482207 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia
NCT02445352 ·Status: COMPLETED ·Phase: PHASE3
-
To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
NCT00726362 ·Status: COMPLETED
-
Genome-wide Analysis of Lipid-lowering Efficacy and Drug Level of Simvastatin and Rosuvastatin
NCT04921657 ·Status: COMPLETED
-
Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers
NCT01415466 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
NCT03217409 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of Anti-inflammatory Effects
NCT00874757 ·Status: COMPLETED
-
Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
NCT03446261 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
NCT02280590 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 Diabetes
NCT02185963 ·Status: COMPLETED ·Phase: PHASE4
-
Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control
NCT02913794 ·Status: COMPLETED
-
Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia
NCT02262143 ·Status: COMPLETED ·Phase: PHASE3